A carregar...
(18)F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors
BACKGROUND: Noninvasively predicting early response to therapy in recurrent pediatric brain tumors provides a challenge. 3,4-dihydroxy-6-[(18)F]fluoro-L-phenylalanine ((18)F-FDOPA) PET/MRI has not been previously studied as a tool to evaluate early response to antiangiogenic therapy in children. The...
Na minha lista:
| Publicado no: | Neurooncol Pract |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909807/ https://ncbi.nlm.nih.gov/pubmed/29692922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npx008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|